CTT Pharmaceutical Holdings and CanniMed Therapeutics Inc. Complete Exclusive Canadian Licensing Agreement for Cannabis Orally Dissolvable Thin Film (ODF) Wafer February 17, 2017 By Flopro
CTT Pharmaceutical Holdings to License to CanniMed Ltd. Novel Cannabis Orally Dissolvable Thin Film (ODF) Wafer Drug Delivery Technology for North American Markets October 24, 2016 By Flopro
CTT Announces the Appointment of Steve Abboud, SME Medicinal Marijuana to Advisory Board February 9, 2015 By Flopro
